Drug class
Non-opioid antitussive; snail-derived glycoprotein cough suppressant
Mechanism of action
A glycoprotein extract from Helix pomatia mucus with proposed peripheral effects on airway sensory receptors and cough-reflex pathways. The precise mechanism is not established, and published clinical evidence supporting efficacy in acute cough is lacking.
General use cases
- Historically marketed in some countries for symptomatic relief of cough. Published evidence is insufficient to establish clinical efficacy for acute cough or acute bronchitis; this entry is historical/regional rather than a confirmed standard treatment.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
